# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-26-104121
Filing Date
2026-03-12
Accepted
2026-03-12 16:07:20
Documents
82
Period of Report
2025-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | bolt-20251231.htm iXBRL | 10-K | 3524444
2 | EX-21.1 | bolt-ex21_1.htm | EX-21.1 | 5106
3 | EX-23.1 | bolt-ex23_1.htm | EX-23.1 | 3527
4 | EX-31.1 | bolt-ex31_1.htm | EX-31.1 | 14893
5 | EX-32.1 | bolt-ex32_1.htm | EX-32.1 | 7942
| Complete submission text file | 0001193125-26-104121.txt |  | 13575346

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | bolt-20251231.xsd | EX-101.SCH | 1513312
84 | EXTRACTED XBRL INSTANCE DOCUMENT | bolt-20251231_htm.xml | XML | 2804388

Mailing Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-665-9295
Bolt Biotherapeutics, Inc. (Filer) CIK: 0001641281 (see all company filings)

EIN.: 472804636 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39988 | Film No.: 26747690
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)